Telomere length and risk of hepatocellular carcinoma: A nested case-control study in Taiwan cancer screening program cohort

Anticancer Research

Volumn 37, Issue 2, 2017, Pages 637-644

  Zeng, Hui ^a,b   Wu, Hui Chen ^a   Wang, Qiao ^a   Yang, Hwai I ^c,d,e   Chen, Chien Jen ^e,f   Santella, Regina M ^a   Shen, Jing ^a  

^a Mailman School of Public Health   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

HCC; Nested case control study; Quantitative PCR; Telomere length

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; FOLLOW UP; GENE FREQUENCY; HEALTH PROGRAM; HUMAN; LEUKOCYTE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SMOKING; TAIWAN; TELOMERE LENGTH; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; EARLY CANCER DIAGNOSIS; ETHNOLOGY; GENETICS; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROCEDURES; RISK FACTOR; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS; TAIWAN; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

EID: 85013674886     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: 10.21873/anticanres.11358     Document Type: Article

References (26)

1. Greider CW: Telomere length regulation. Annu Rev Biochem 65: 337-365, 1996.
2. Huffman KE, Levene SD, Tesmer VM, Shay JW and Wright WE: Telomere shortening is proportional to the size of the Grich telomeric 3'-overhang. J Biol Chem 275: 19719-19722, 2000.
3. Wright WE, Tesmer VM, Huffman KE, Levene SD and Shay JW: Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev 11: 2801-2809, 1997.
4. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L and DePinho RA: Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406: 641-645, 2000.
5. Maser RS and DePinho RA: Connecting chromosomes, crisis, and cancer. Science 297: 565-569, 2002.
6. Zhang Y, Shen J, Ming W, Lee YP and Santella RM: Telomere length in hepatocellular carcinoma and paired adjacent non-tumor tissues by quantitative PCR. Cancer Invest 25: 668-677, 2007.
7. Satyanarayana A, Manns MP and Rudolph KL: Telomeres and telomerase: a dual role in hepatocarcinogenesis. Hepatology 40: 276-283, 2004.
8. Oh B-K, Jo Chae K, Park C, Kim K, Jung Lee W, Han K-h and Nyun Park Y: Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis. J Hepatol 39: 786-792, 2003.
9. Oh B-K, Kim Y-J, Park C and Park YN: Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol 166: 73-80, 2005.
10. Oh BK, Kim H, Park YN, Yoo JE, Choi J, Kim KS, Lee JJ and Park C: High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis. Lab Invest 88: 144-152, 2008.
11. Liu J, Yang Y, Zhang H, Zhao S, Liu H, Ge N, Yang H, Xing JL and Chen Z: Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a casecontrol analysis. Cancer 117: 4247-4256, 2011.
12. Fu X, Wan S, Hann HW, Myers RE, Hann RS, Au J, Chen B, Xing J and Yang H: Relative telomere length: a novel noninvasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection. Eur J Cancer 48: 1014-1022, 2012.
13. Wu HC, Wang Q, Wang LW, Yang HI, Ahsan H, Tsai WY, Wang LY, Chen SY, Chen CJ and Santella RM: Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis 28: 995-999, 2007.
14. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S and Ahlbom A: Calculating measures of biological interaction. Eur J Epidemiol 20: 575-579, 2005.
15. Cesare AJ and Reddel RR: Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11: 319-330, 2010.
16. Wentzensen IM, Mirabello L, Pfeiffer RM and Savage SA: The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 20: 1238-1250, 2011.
17. Unryn BM, Hao D, Gluck S and Riabowol KT: Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer. Clin Cancer Res 12: 6345-6350, 2006.
18. Hou L, Zhang X, Gawron AJ and Liu J: Surrogate tissue telomere length and cancer risk: shorter or longer? Cancer Lett 319: 130-135, 2012.
19. Nakamura K, Yuh K, Sugyo S, Shijo H, Kimura N and Okumura M: Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Gastroenterology 111: 156-164, 1996
20. Zhu CW, Chen M, Luo XR, Wang HY, Wang LH, Wu JH, Li M, Zhang XH, Zhu W, Ye JZ and Qian F: Interferon alpha on expression of hTERT mRNA in peripheral blood mononuclear cells of patients with chronic hepatitis B. Clin Dev Immunol 2011: 920146, 2011.
21. Kawanishi S and Oikawa S: Mechanism of telomere shortening by oxidative stress. Ann NY Acad Sci 1019: 278-284, 2004.
22. Song Z, von Figura G, Liu Y, Kraus JM, Torrice C, Dillon P, Rudolph-Watabe M, Ju Z, Kestler HA, Sanoff H and Lenhard Rudolph K: Lifestyle impacts on the aging-associated expression of biomarkers of DNA damage and telomere dysfunction in human blood. Aging Cell 9: 607-615, 2010.
23. Huzen J, Wong LSM, van Veldhuisen DJ, Samani NJ, Zwinderman AH, Codd V, Cawthon RM, Benus GFJD, van der Horst ICC, Navis G, Bakker SJL, Gansevoort RT, de Jong PE, Hillege HL, van Gilst WH, de Boer RA and van der Harst P: Telomere length loss due to smoking and metabolic traits. J Intern Med 275: 155-163, 2014.
24. Cawthon RM: Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47, 2002.
25. Cawthon RM: Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37: e21, 2009.
26. O'Callaghan N, Dhillon V, Thomas P and Fenech M: A quantitative real-time PCR method for absolute telomere length. BioTechniques 44: 807-809, 2008.